| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -797K | 100% | $3.86 | -$3.08M |
| Net | -6 | -797K | -100% | -$3.08M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 10%+ Owner | $61.1M | Jun 17, 2024 | ||
| Denise Scots-Knight | Chief Executive Officer | $4.25M | -$845K | -16.6% | Jan 25, 2025 |
| Charles Sermon | General Counsel | $1.19M | -$295K | -19.9% | Jan 25, 2025 |
| Christine Fox | Chief Financial Officer | $641K | -$270K | -29.6% | Jan 25, 2025 |
| John A. Lewicki | Chief Scientific Officer | $509K | -$154K | -23.2% | Jan 25, 2025 |
| Alexandra Hughes-Wilson | Chief Patient Access and Commercial Planning | $369K | -$1.05M | -74% | Jan 25, 2025 |
| Michael S. Wyzga | Director | $156K | Feb 5, 2025 | ||
| Jeremy Bender | Director | $106K | Feb 5, 2025 | ||
| Pierre Jacquet | Director | $55.6K | Feb 5, 2025 | ||
| Deepika Pakianathan | Director | $55.6K | -$466K | -89.4% | Feb 5, 2025 |
| Annalisa Jenkins | Director | $55.6K | Feb 5, 2025 | ||
| Anders Ekblom | Director | $55.6K | Feb 5, 2025 | ||
| Marc J. Yoskowitz | Director | $55.6K | Feb 5, 2025 | ||
| Daniel Shames | Director | $55.6K | Feb 5, 2025 | ||
| Justin Hunter Roberts | Director | Jan 1, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|